Bi-Specific Antibody Study

We conducted an expansive FTO review of the bi-specific antibody space for a small client seeking to be acquired by a high-profile organization in the same space. We screened thousands of results to help determine the client’s freedom to operate. Based on our…

Continue Reading Bi-Specific Antibody Study

Due Diligence: Medical Devices Company acquisition

A Japanese-based client in a multi-million dollar deal sought to acquire a U.S. based company that makes medical devices (“the Technology”). The due diligence of the target company and the Technology included a thorough review of the entire IP portfolio and related files.…

Continue Reading Due Diligence: Medical Devices Company acquisition

Nanoparticle Delivery Systems and Bi-Specific Antibodies

Drafting and filing applications directed to nanoparticle delivery composition systems involving bi-specific antibodies, where the nanoparticle contains both an antihistamine and a FcԑRI targeting moiety. The targeting moiety binds the nanoparticle to a target cell and blocks target cell degranulation mediated by FcԑRI…

Continue Reading Nanoparticle Delivery Systems and Bi-Specific Antibodies

End of content

No more pages to load